Regeneron's (REGN) Q1 Earnings & Sales Surpass Estimates
May 05, 2020 at 11:54 AM EDT
Regeneron Pharmaceuticals, Inc. reported better-than-expected results for the first quarter of 2020, wherein both earnings and sales beat estimates.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|